AGENDA
MAHESH BHALGAT
COO, Syngene International Ltd

Dr Bhalgat is the COO at Syngene International Limited & recognised for his contribution to the commercialisation of diagnostic kits, biopharmaceuticals and WHO pre-qualification of vaccines. n a career spanning over 25 years in the field of biotechnology and biologics, Dr Bhalgat is recognised for his contribution to the commercialisation of diagnostic kits, biopharmaceuticals and WHO pre-qualification of vaccines. He has a rich experience in diverse areas of biotechnology such as biotherapeutics, vaccines, ag-biotech, and research reagents and has been associated with companies such as Amgen, Monsanto, Celera Genomics, Thermo Fisher,Biological E. A PhD in Medicinal Chemistry from the University of Utah, he is the Co-Chair of CII?s National Committee of Biotechnology as well as a member of the Biomeriux Scientific Advisory Board, France, United States Pharmacopeia, GCBA committee and the Indian Pharmacopeial Commission.

Background: Ph.D. in Field Of Study Pharmacy - Medicinal Chemistry in University of Utah.